San‐Gang Wu

Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Yu‐Pei Chen, Xu Liu, Qin Zhou et al. · The Lancet · 2021 · 234 citations

Medicine, Oncology, Pharmacology +12

Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancer

San‐Gang Wu, Zhen‐Yu He, Juan Zhou et al. · The Breast · 2013 · 118 citations · Full text

Medicine, Oncology, Pathology +15

Oleoylethanolamide exerts anti-inflammatory effects on LPS-induced THP-1 cells by enhancing PPARα signaling and inhibiting the NF-κB and ERK1/2/AP-1/STAT3 pathways

Lichao Yang, Han Guo, Ying Li et al. · Scientific Reports · 2016 · 110 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis

Juan Zhou, San‐Gang Wu, Jiayuan Sun et al. · Journal of Cancer Research and Clinical Oncology · 2016 · 99 citations · Full text

Medicine, Oncology, Radiation Oncology +11

Patterns of Distant Metastasis Between Histological Types in Esophageal Cancer

San‐Gang Wu, Wen‐Wen Zhang, Jiayuan Sun et al. · Frontiers in Oncology · 2018 · 92 citations · Full text

Medicine, Oncology, Pathology +17